Sana Biotechnology, Inc. (SANA) › Operating Cash FlowSana Biotechnology, Inc. (SANA) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2019: -$85.52M2020: -$137.98M2021: -$251.05M2022: -$290.05M2023: -$253.58M2024: -$223.15M2025: -$143.83M-$143.83M2019Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$143.83M+35.5%2024-$223.15M+12.0%2023-$253.58M+12.6%2022-$290.05M-15.5%2021-$251.05M-81.9%2020-$137.98M-61.3%2019-$85.52M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share